PA

Parth Atulkumar Surati

Active Director Director DIN 11699491
DIN 11699491 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Parth Atulkumar Surati

Parth Atulkumar Surati is a Director at Valorix Biosciences Private Limited (since 2026).

DIN 11699491
Primary Designation Director
First Appointment 29 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Valorix Biosciences Private Limited U21004GJ2026PTC184466
Director29 Sep 20262026Active

Board colleagues of Parth Atulkumar Surati

NameDINCompanyDesignation
Ilaxiben Atulkumar Surati11978100Valorix Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Valorix Biosciences Private Limited
Premium access

Shareholding and investment profile for Parth Atulkumar Surati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parth Atulkumar Surati

Parth Atulkumar Surati currently holds 1 directorship: Valorix Biosciences Private Limited (Director, since 29 Sep 2026).

Parth Atulkumar Surati was first appointed on 29 Sep 2026 as Director at Valorix Biosciences Private Limited.

The current boards of Parth Atulkumar Surati's companies include Ilaxiben Atulkumar Surati (Valorix Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available